9 am-12 noon

Hands-On Computer Workshop on HIV Sequence, Immunology, and Vaccine Databases
( first-come first-served up to 80 people)

9 am-3 pm

Program Committee Workshop for New Investigators and Trainees
( first-come first-served up to 400 people)
 

12-1 pm

Program Committee Luncheon for Fellow/Graduate Student Travel Grant and
International Scholarship Recipients

(by invitation only)

3-5 pm

Symposium
Scaling Up HIV Care in the Developing World

Plenary

The HIV Envelope Glycoprotein: Interactions and Conformational Changes
Stephen Harrison
Children's Hosp, Harvard Med Sch, Boston, MA

Plenary

 Lipodystrophy:
Fitting the Pieces of the Puzzle
Peter Reiss
Academic Med Ctr, Amsterdam,
The Netherlands

Plenary

Vaccine Protection
against Human Papillomaviruses

Kathrin Jansen
VaxGen, Brisbane, CA

post-conference activities
including:

debriefing sessions

+

investigator meetings

+

working group meetings

+

affiliated events

Plenary

 Controversies in the Use of Nevirapine for Prevention of Mother-to-Child Transmission
James McIntyre
Univ of the Witwatersrand, Chris Hani Baragwanath Hosp, Johannesburg, South Africa

Plenary

The Biology of HIV-1 Transmission and Re-Infection
Julie Overbaugh
Fred Hutchinson Cancer Res Ctr, Seattle, WA

Plenary

 Making Sense of
HIV Disease Pathogenesis
Daniel Douek
Vaccine Res Ctr, NIAID, NIH, Bethesda, MD

Break

4 Oral Abstract Sessions

 Neuropathogenesis: Molecular Markers and Therapeutic Advances

Diagnosis and Treatment of HIV Infection in Developing Countries



Cellular and Viral Factors in Virus-Host Interplay



Complications of Antiretroviral Therapy

4 Oral Abstract Sessions

Pregnancy and Prevention of Perinatal HIV Transmission

Clinical Pharmacology: New Agents, Interactions, and Predictors of Virologic Response

Determinants Driving Humoral and Cellular Immunity in Monkeys and Humans

HIV Drug Resistance: Selection, Persistence, and Impact on Response

4 Oral Abstract Sessions

Prevention Strategies: Vaccines and Microbicides


Infectious Complications: Prevention and Treatment




Viral and Cellular Determinants of Pathogenesis


Antiretroviral Therapy: New Agents, New Combinations, and Virologic Responses

Lunch

Lunch

Lunch

Poster Sessions

Poster Sessions

Poster Sessions

3 Poster
Discussions

NK Cells in HIV Infection


Impact of Antiretroviral Therapy during Pregnancy


Antiretroviral Therapy: Long-Term Immunologic Outcomes

3 Poster
Discussions

The Role of LEDGF in Viral Replication


Therapeutic Drug Monitoring



Interactions among RTI Resistance Mutations

3 Poster
Discussions

Emerging Issues in Monkey Pathogenesis Models

Immunological Factors in HIV-Infected Infants, Children, and Adolescents

Mental Health and Substance Abuse

Break

Break

3 Symposia

Epidemiology of HIV: New Insights

Chemokine Receptor Blockade:
Bench to Bedside

 Heart and HAART

3 Symposia

Critical Pediatric Issues in
Developing Countries

Recent Advances in HIV
Vaccine Development


Antiretroviral Drug Discovery: Exploiting New Targets

1 Oral Abstract Session

Hepatitis Virus Co-Infection

1 Oral Abstract Session

The Evolving HIV Epidemic: Risk Behavior, Incidence, and Prevalence

2 Symposia

HIV Replication: Co-Factors
and Host Restrictions

Key Topics in Antiretroviral  Therapy

Opening Plenary and Keynote Session

 Bernard Fields Memorial Lecture 
Natural Resistance to HIV Infection: The Vif-APOBEC Interaction
Michael Malim
King’s Coll London, UK

Keynote Presentation
TBD

Policy Forum

The Global Challenge of Infectious Diseases: The Evolving Role of the NIH in Basic and Clinical Research
Anthony Fauci
Natl Inst of Allergy and Infectious Diseases, NIH, DHHS, Bethesda, MD, USA

Wednesday Feb. 23, 2005

Thursday Feb. 24, 2005

Friday Feb. 25, 2005

Poster Hall Open
All posters will be available for viewing for the duration of the conference.

Poster Sessions

Viral Replication: Early Events, Fusion, and Tropism

The Role of LEDGF in Viral Replication

Cellular Co-Factors


Host-Cell Restriction Factors: Vif, Apobec, Trim5, and Cyclophilin

Virus-Cell Interactions: Trans Infection and Inhibition

Virus-Macrophage Interactions


Virus-Host Interactions: Antiviral Responses and Mucosal Infection

Construction and Evaluation of Vaccine Strategies

Enhancing Immune Responses to Vaccines

HIV-1 Neutralizing Antibodies



Immune-Based Therapies

New Antiretroviral Agents: New Classes

Diagnosing Primary HIV Infection


Therapeutic Intervention during Primary Infection

Response to Antiretroviral Therapy in Developing Countries

Adherence to Antiretroviral Therapy in Developing Countries

Generic Antiretroviral Therapy


Pharmacology of NRTIs



Pharmacology of NNRTIs


Pharmacology of Protease Inhibitors


Transmission of HIV Drug Resistance

HIV Drug Resistance: Selection, Evolution, and Persistence

Interactions among RTI Resistance Mutations

Immunological Factors in HIV-Infected Infants, Children, and Adolescents

T-Cell Responses in Children



Co-Factors Impacting HIV Infection in Children

NRTI Toxicities


Pharmacogenetics of NNRTI Hepatoxicity

Abacavir Hypersensitivity and Injection Site Reactions


Opportunistic Infections and Bacterial Infections in the Setting of HAART

Non-Tuberculous Mycobacterial Infections

Tuberculosis and HIV


HCV Virology


HCV Immune Responses



HCV Co-Infection: Epidemiology


HCV Co-Infection: Natural History

Risk Behavior Studies

Behavior and Counseling for Prevention

Mental Health and Substance Abuse

Health Services and Cost Effectiveness

Poster Sessions

Poster Sessions

Viral Replication: Regulation of Viral Gene Expression

Viral Replication: Late Events and Assembly

Viral Accessory Genes


Molecular Epidemiology: Recombination and Recombinants

Molecular Epidemiology: Selection and Evolution

Molecular Epidemiology: Linkage


Molecular Epidemiology: Diversity of Specific Genes

Molecular Epidemiology: Regional Characteristics

Neuropathogenesis: Therapy and Clinical Studies

Neuropathogenesis: Clinical Correlates and Observational Studies

T-Cell Epitopes and Virus Escape

T-Cell Subsets and the Thymus in HIV Infection

Cellular Responses in Exposed Uninfected Individuals

CD8 Responses


CD8 T-Cell Dysfunction in HIV Infection

Shifts in Cellular Responses during HIV/SIV Infection

Changes in Cellular Responses with Antiretroviral Therapy

Vaccine Trials in Human Subjects



Therapeutic Vaccination of Infected Patients

Strategies of Antiretroviral Therapy


Adherence, Quality of Life, and Factors Related to Treatment

Therapeutic Drug Monitoring


Pharmacology: Entry Inhibitors and P-Glycoprotein

Pharmacology: Drug Stability and Bioequivalence


Impact of Drug Resistance on Virologic Response and Clinical Outcomes

Resistance to Specific Drugs and Drug Combinations

Drug Resistance Testing: New Methods and Interpretations

Simplifying CD4 Testing


Diagnostics: Measuring the Consequences of Antiretroviral Therapy

HIV Genotyping Assays



Vertical Transmission and Antiretroviral Resistance

Uninfected Infants Born to HIV+ Women

Impact of Antiretroviral Therapy during Pregnancy

HIV and Reproductive Health



Racial and Gender Differences in Laboratory Values

Cardiovascular Risk and Disease

HAART and Hypertension

Erectile Dysfunction and Hypogonadism

HSV-2 and other STDs

Human Papilloma Virus Infection and Malignancies

KSHV and Kaposi's Sarcoma

Other AIDS-Associated Malignancies

HBV Co-Infection

GB Virus Type C Co-Infection

Morbidity and Mortality

Incidence and Prevalence

Infection and Disease Progression